Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day-1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Vergleichende Bewertung der Wirksamkeit und Sicherheit zweier Terbinafin-Dosierungen (500 und 1000 mg/Tag) in der Therapie der kutanen und lymphokutanen Sporotrichose-Reference-Cited by-同舟云学术

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day-1) in the treatment of cutaneous or lymphocutaneous sporotrichosis. Vergleichende Bewertung der Wirksamkeit und Sicherheit zweier Terbinafin-Dosierungen (500 und 1000 mg/Tag) in der Therapie der kutanen und lymphokutanen Sporotrichose

Published:2004-02 Issue:1-2 Volume:47 Page:62-68
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Chapman S. W.,Pappas P.,Kauffmann C.,Smith E. B.,Dietze R.,Tiraboschi-Foss N.,Restrepo A.,Bustamante A. B.,Opper C.,Emady-Azar S.,Bakshi R.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Reference27 articles.

1. Outbreak of Sporotrichosis among Tree Nursery Workers

2. CUTANEOUS MANIFESTATIONS OF FUNGAL INFECTION

3. Sporotrichosis

4. Administration of potassium iodide to normal volunteers does not increase killing ofSporothrix schenckiiby their neutrophils or monocytes

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is terbinafine an effective treatment for feline sporotrichosis?;Veterinary Record;2024-08-15

2. Antifungal efficacy of imidazo[1,2-a]pyrazine-based thiosemicarbazones and thiazolidinediones against Sporothrix species;Future Microbiology;2023-10-26

3. Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae;Indian Journal of Dermatology;2023-09

4. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis;Journal of the European Academy of Dermatology and Venereology;2023-05-30

5. Fungal Infections;Dermatology in Public Health Environments;2023